Developer docs
API playgroundTry for free, no card

Search company profiles

KARADA内科クリニック

Full company profile

uuid00ssw1y

Namestring
KARADA内科クリニック
Legal namestring
、医療法人社団OURS
Websiteurl
just-in-case.jp
Company typeenum
Private
Founded yearstring
-
Descriptiontext

KARADA内科クリニック (KARADA Internal Medicine Clinic) is a private medical corporation (医療法人社団OURS) headquartered in Gotanda, Tokyo, that operates a nationwide Japanese online telemedicine service branded JUST IN CASE. Its core function is the prescription and direct-to-consumer delivery of medications for sexually transmitted infection (STI) prevention: HIV PrEP (Tafero EM, daily or on-demand), HIV PEP (Taffic, a 30-day post-exposure course), and DOXY PEP (doxycycline, for syphilis, gonorrhea, and chlamydia post-exposure prophylaxis), supported by optional at-home STI test kits. Consultations are conducted entirely through LINE (no dedicated app required) with physicians credentialed in infectious disease, and medications are shipped discreetly via Yamato Transport with home delivery or locker pickup.

The underlying technology is a web + LINE-based synchronous telemedicine workflow integrated with mail-order pharmacy fulfillment and shipping logistics. Pricing is unit-based for single courses and subscription-based for ongoing PrEP (28–80 day cycles) and DOXY-PEP (28-day regular delivery). Patients also pay separately for optional postal STI tests. The only disclosed integration is the LINE Official Account used as the primary booking and consultation surface.

The business model is a direct-to-consumer specialist clinic monetizing prescription consultations and medication fulfillment, with subscriptions on PrEP and DOXY-PEP providing recurring revenue and PEP functioning as a high-ticket one-off. The customer base is horizontal: individual Japanese adults with elevated HIV/STI risk who are seeking discreet, rapid access to prevention medications and testing. The affiliated physical KARADA内科クリニック 五反田 clinic serves as a referral point for in-person consultations. Since launch, JUST IN CASE has expanded its scope to include additional "delicate" categories such as 肥満症 (obesity), ED, and AGA.

Short descriptiontext

JUST IN CASE is a Japan-wide online telemedicine clinic operated by KARADA内科クリニック that prescribes and delivers HIV PrEP, HIV PEP, DOXY PEP, and at-home STI tests via LINE-based consultations and Yamato shipping for individual Japanese consumers.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
online telemedicine services, STI prevention medication, HIV pre-exposure prophylaxis, sexual health consultations, mail-order prescription services
Industry3 codes
1Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment
CodeHLALAIALPrimaryYes
2DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
CodeHLALAIAAPrimaryNo
3Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
CodeHLALAAADPrimaryNo
NAICS code2 codes
  • Offices of Physicians (except Mental Health Specialists)621111
  • Other Ambulatory Health Care Services6219
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Online Telemedicine Healthcare Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1HIV PEP prescription and medication sales
TypeOne Time License
Description

One-time prescription sale of HIV post-exposure prophylaxis (PEP) medication (Taffic), including 30-day supply of antiretrovirals, physician consultation, and an at-home HIV/hepatitis B test kit. Additional optional follow-up consultation available.

just-in-case.jp
2HIV PrEP prescription and medication sales
TypeSubscription Recurring
Description

Prescription and sale of HIV pre-exposure prophylaxis (PrEP) medication (Tafero EM / generic), available as daily or on-demand dosing. Sold as one-time purchase, or via subscription with scheduled refills (28–80 day cycles). Includes at-home test kit sets (start, minimum, standard) for HIV/hepatitis B/syphilis screening. 6-month prescriptions require prior Tafero EM use history.

just-in-case.jp
3DOXY PEP prescription and medication sales
TypeSubscription Recurring
Description

Prescription and sale of doxycycline post-exposure prophylaxis (DOXY PEP) — an antibiotic regimen for prevention of syphilis, gonorrhea, and chlamydia after sexual contact. Sold in packs of 1, 5, 10, 20, or 30 doses, with optional subscription (regular delivery every 28 days) and optional add-ons (probiotics, anti-nausea medication). Regular at-home testing strongly recommended and required for continued purchase.

just-in-case.jp
4Optional postal STI testing
TypeOne Time License
Description

Mailed self-collection STI test kits sold as add-ons to prescription services: HIV/hepatitis B (home test, immediate results), syphilis, gonorrhea/chlamydia (mailed to clinic, results in 3–4 days after receipt).

just-in-case.jp
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details7 tiers
1HIV PEP — single 30-day course (Taffic)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

60,000 JPY (includes consultation, 30-day Taffic prescription, HIV + hepatitis B at-home test kit) + 500 JPY shipping. Optional follow-up consultation: 5,500 JPY.

just-in-case.jp
2DOXY PEP — single-dose packs
ModelUnit PricingBilling cadencePay-as-you-go
Notes

1 dose: 3,900 JPY; 5 doses: 7,700 JPY; 10 doses: 11,000 JPY; 20 doses: 21,000 JPY; 30 doses: 31,000 JPY; all + 500 JPY shipping per shipment.

just-in-case.jp
3DOXY PEP — subscription (regular delivery)
ModelSubscriptionBilling cadenceMonthly
Notes

5-dose subscription: 6,600 JPY per delivery; 10-dose subscription: 9,900 JPY per delivery. Delivery every 28 days. Monthly STI testing required; may be required to continue subscription.

just-in-case.jp
4HIV PrEP daily — one-time purchase (no test kit)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

1-month (30 tablets): 12,100 JPY; 3-month (90 tablets): 19,800 JPY; 6-month (180 tablets): 39,600 JPY. 6-month option requires prior Tafero EM use.

just-in-case.jp
5HIV PrEP daily — one-time purchase (with test kit set)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

1-month + test kit set: from 22,000 JPY; 3-month + test kit set: 20,900 JPY (mini-mum/standard set); 6-month + 2 test kits: 39,600 JPY.

just-in-case.jp
6HIV PrEP on-demand — single bottle (30 tablets)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Subscription on-demand: 1 bottle (30 tablets) with follow-up set, 80-day cycle. On-demand PrEP only for male patients.

just-in-case.jp
7Optional postal STI tests
ModelUnit PricingBilling cadencePay-as-you-go
Notes

60-day HIV + hepatitis B: 2,200 JPY; gonorrhea/chlamydia/syphilis: 5,500 JPY; HIV/hepatitis B/syphilis (combined): 3,300 JPY; gonorrhea/chlamydia (combined): 4,400 JPY.

just-in-case.jp
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

KARADA内科クリニック runs the JUST IN CASE online telemedicine service that provides remote physician consultations and prescriptions for STI prevention medications, including HIV PrEP (Tafero EM), HIV PEP (Taffic), and DOXY PEP (Doxycycline). Consultations are conducted entirely via LINE without requiring app installation, and prescribed medications are shipped nationwide via Yamato Transport with next-day delivery, discreet plain packaging, and optional locker pickup. The service also sells optional at-home STI test kits for HIV, hepatitis B, syphilis, gonorrhea, and chlamydia.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • HIV prevention effectiveness of 99%+ with consistent daily PrEP use
+2 more records
Product overview1 text field

JUST IN CASE is an online telemedicine service operated by KARADA内科クリニック (KARADA Internal Medicine Clinic), offering prescription medications for sexually transmitted infection (STI) prevention. The core product portfolio consists of three main offerings: HIV PrEP (プレップ) with TAFFERO EM for pre-exposure prevention, HIV PEP (ペップ) with Taffic for post-exposure emergency prevention, and DOXY PEP (ドキシペップ) using Doxycycline for prevention of syphilis, gonorrhea, and chlamydia. All services are delivered through online medical consultations with certified infectious disease specialists, with medications shipped discreetly via Yamato Transport. Optional mail-in test kits complement these offerings for pre-treatment screening and post-treatment verification. The service operates as a direct-to-consumer online clinic, distinct from the affiliated physical KARADA内科 clinics.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

Hetero Drugs is an Indian multinational pharmaceutical company that manufactures Tafero EM (タフェロEM) as a generic antiretroviral. JUST IN CASE imports the generic version (Tafero EM / Instgra) through licensed pharmaceutical importer つばめLabo for use in its PrEP program. Hetero's generic is described as having no significant safety difference from originator drugs and being widely used internationally.

2KARADA内科クリニック (physical clinic)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

KARADA内科クリニ is the affiliated physical clinic operated by Medical Corporation OURS. It serves as the physical referral destination for patients using the JUST IN CASE online service who prefer or require in-person consultations, as well as the physical location where the online service's medical director and staff are based.

just-in-case.jp
3大阪大学 忽那教授 (Professor Kutsuna, Osaka University)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Professor Kutsuna of Osaka University, a leading infectious disease researcher, collaborated with Dr. Sato on an in-depth YouTube discussion about DOXY-PEP. This collaboration serves as a key educational and credibility partnership, lending academic authority to JUST IN CASE's DOXY-PEP offering.

just-in-case.jp
Strategic tierMinorTypeGTM or Marketing Partner
Description

The JUST IN CASE DOXY-PEP service was featured on AbemaTV (Abema News), providing earned media coverage that drives awareness and customer acquisition.

5つばめLabo (Tsubame Labo)
Strategic tierCoreTypeTechnology or Integration
Description

Licensed pharmaceutical importer that sources and imports generic antiretrovirals (Tafero EM and Instgra) from Hetero Drugs and other overseas manufacturers for use in the JUST IN CASE PrEP program. Acts as the import compliance and supply chain partner for overseas generic medications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US DTC telehealth platform (now part of Thirty Madison) historically offering PrEP, STI testing, contraception, and home delivery prescriptions. Closely comparable model on PrEP/STI prevention telemedicine with at-home testing integration.

2あおぞらクリニック (Aozora Clinic)
TypeDirect peer
Description

Japanese clinic network with multiple locations explicitly marketing HIV PrEP services online. Closest direct domestic peer — competes for the same PrEP/PEP patient persona in Japan with overlapping telemedicine and consultation offerings.

TypeDirect peer
Description

US-based, PrEP-focused telehealth platform providing online PrEP prescriptions, at-home STI testing, and direct mail delivery with a similar specialty-prevention model to JUST IN CASE. Direct international comparable for the PrEP-specific vertical.

4フィットクリニック (Fit Clinic)
TypeEmerging player
Description

Japanese online clinic offering ED, AGA, weight loss, and other sensitive prescriptions with online consultation and mail delivery. Emerging Japanese comparable with similar product breadth (AGA, ED, weight) that may eventually expand into STI prevention.

TypeBroad incumbent
Description

Large Japanese digital-health and physician platform operating MR-kun, QOL-kun, and other clinician-targeted services, with growing consumer-facing telemedicine. Broad incumbent with the resources to enter or absorb STI-prevention offerings, making it the most plausible large-scale competitive threat.

6ユナイテッドクリニック (United Clinic)
TypeDirect peer
Description

Japanese men's-health clinic chain offering ED, AGA, and sexual health treatments with online consultation services. Comparable patient persona, comparable pricing structure, and comparable focus on discreet access to sensitive prescriptions.

7プライベートクリニック (Private Clinic)
TypeDirect peer
Description

Japanese men's-health clinic specializing in ED, AGA, and PrEP prescriptions with online consultation options. Direct competitor for Japanese patients seeking discreet access to sexual-health prescriptions, with overlapping telemedicine-and-mail-fulfillment pattern.

TypeDirect peer
Description

Large Japanese men's-health clinic chain focused on ED, AGA, and sexual health prescriptions. Comparable in addressing the same stigma-laden, cash-pay, treatment-oriented segment of Japanese patients, though predominantly in-person rather than online-first.

TypeEmerging player
Description

Japanese digital health company providing online medical content, doctor-matching, and clinician support tools with adjacent exposure to chronic-condition patient engagement. Emerging player with potential to extend into direct DTC prescription telemedicine.

TypeBroad incumbent
Description

US-listed DTC telehealth platform offering subscription-based prescription treatments for sensitive conditions (ED, hair loss, PrEP, mental health, weight loss) with discrete home delivery. Highly comparable business model: cash-pay subscription, online consultation, mail fulfillment, DTC sensitive-health positioning at much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KARADA内科クリニック

Online Telemedicine Healthcare Servicesjust-in-case.jp

JUST IN CASE is a Japan-wide online telemedicine clinic operated by KARADA内科クリニック that prescribes and delivers HIV PrEP, HIV PEP, DOXY PEP, and at-home STI tests via LINE-based consultations and Yamato shipping for individual Japanese consumers.

What KARADA内科クリニック does

KARADA内科クリニック (KARADA Internal Medicine Clinic) is a private medical corporation (医療法人社団OURS) headquartered in Gotanda, Tokyo, that operates a nationwide Japanese online telemedicine service branded JUST IN CASE. Its core function is the prescription and direct-to-consumer delivery of medications for sexually transmitted infection (STI) prevention: HIV PrEP (Tafero EM, daily or on-demand), HIV PEP (Taffic, a 30-day post-exposure course), and DOXY PEP (doxycycline, for syphilis, gonorrhea, and chlamydia post-exposure prophylaxis), supported by optional at-home STI test kits. Consultations are conducted entirely through LINE (no dedicated app required) with physicians credentialed in infectious disease, and medications are shipped discreetly via Yamato Transport with home delivery or locker pickup.

The underlying technology is a web + LINE-based synchronous telemedicine workflow integrated with mail-order pharmacy fulfillment and shipping logistics. Pricing is unit-based for single courses and subscription-based for ongoing PrEP (28–80 day cycles) and DOXY-PEP (28-day regular delivery). Patients also pay separately for optional postal STI tests. The only disclosed integration is the LINE Official Account used as the primary booking and consultation surface.

The business model is a direct-to-consumer specialist clinic monetizing prescription consultations and medication fulfillment, with subscriptions on PrEP and DOXY-PEP providing recurring revenue and PEP functioning as a high-ticket one-off. The customer base is horizontal: individual Japanese adults with elevated HIV/STI risk who are seeking discreet, rapid access to prevention medications and testing. The affiliated physical KARADA内科クリニック 五反田 clinic serves as a referral point for in-person consultations. Since launch, JUST IN CASE has expanded its scope to include additional "delicate" categories such as 肥満症 (obesity), ED, and AGA.

KARADA内科クリニック firmographics

Firmographics
Name
KARADA内科クリニック
Legal name
、医療法人社団OURS
Website
https://just-in-case.jp
Company type
Private
Operating status
Operating
Short description
JUST IN CASE is a Japan-wide online telemedicine clinic operated by KARADA内科クリニック that prescribes and delivers HIV PrEP, HIV PEP, DOXY PEP, and at-home STI tests via LINE-based consultations and Yamato shipping for individual Japanese consumers.
Ownership category
akta.pro rank

KARADA内科クリニック industry classification

Industry
Product category
Online Telemedicine Healthcare Services
NAICS
Offices of Physicians (except Mental Health Specialists) (621111), Other Ambulatory Health Care Services (6219)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment (HLALAIAL)
akta.pro secondary industries
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

Keywords

  • Online telemedicine services
  • STI prevention medication
  • HIV pre-exposure prophylaxis
  • Sexual health consultations
  • Mail-order prescription services

Where KARADA内科クリニック is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

KARADA内科クリニック business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. HIV PEP prescription and medication sales: One-time prescription sale of HIV post-exposure prophylaxis (PEP) medication (Taffic), including 30-day supply of antiretrovirals, physician consultation, and an at-home HIV/hepatitis B test kit. Additional optional follow-up consultation available.
  2. HIV PrEP prescription and medication sales: Prescription and sale of HIV pre-exposure prophylaxis (PrEP) medication (Tafero EM / generic), available as daily or on-demand dosing. Sold as one-time purchase, or via subscription with scheduled refills (28–80 day cycles). Includes at-home test kit sets (start, minimum, standard) for HIV/hepatitis B/syphilis screening. 6-month prescriptions require prior Tafero EM use history.
  3. DOXY PEP prescription and medication sales: Prescription and sale of doxycycline post-exposure prophylaxis (DOXY PEP) — an antibiotic regimen for prevention of syphilis, gonorrhea, and chlamydia after sexual contact. Sold in packs of 1, 5, 10, 20, or 30 doses, with optional subscription (regular delivery every 28 days) and optional add-ons (probiotics, anti-nausea medication). Regular at-home testing strongly recommended and required for continued purchase.
  4. Optional postal STI testing: Mailed self-collection STI test kits sold as add-ons to prescription services: HIV/hepatitis B (home test, immediate results), syphilis, gonorrhea/chlamydia (mailed to clinic, results in 3–4 days after receipt).

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goHIV PEP — single 30-day course (Taffic)
Unit PricingPay-as-you-goDOXY PEP — single-dose packs
SubscriptionMonthlyDOXY PEP — subscription (regular delivery)
Unit PricingPay-as-you-goHIV PrEP daily — one-time purchase (no test kit)
Unit PricingPay-as-you-goHIV PrEP daily — one-time purchase (with test kit set)
Unit PricingPay-as-you-goHIV PrEP on-demand — single bottle (30 tablets)
Unit PricingPay-as-you-goOptional postal STI tests

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

KARADA内科クリニック product offering

Product offering

Core offering

KARADA内科クリニック runs the JUST IN CASE online telemedicine service that provides remote physician consultations and prescriptions for STI prevention medications, including HIV PrEP (Tafero EM), HIV PEP (Taffic), and DOXY PEP (Doxycycline). Consultations are conducted entirely via LINE without requiring app installation, and prescribed medications are shipped nationwide via Yamato Transport with next-day delivery, discreet plain packaging, and optional locker pickup. The service also sells optional at-home STI test kits for HIV, hepatitis B, syphilis, gonorrhea, and chlamydia.

Product overview

JUST IN CASE is an online telemedicine service operated by KARADA内科クリニック (KARADA Internal Medicine Clinic), offering prescription medications for sexually transmitted infection (STI) prevention. The core product portfolio consists of three main offerings: HIV PrEP (プレップ) with TAFFERO EM for pre-exposure prevention, HIV PEP (ペップ) with Taffic for post-exposure emergency prevention, and DOXY PEP (ドキシペップ) using Doxycycline for prevention of syphilis, gonorrhea, and chlamydia. All services are delivered through online medical consultations with certified infectious disease specialists, with medications shipped discreetly via Yamato Transport. Optional mail-in test kits complement these offerings for pre-treatment screening and post-treatment verification. The service operates as a direct-to-consumer online clinic, distinct from the affiliated physical KARADA内科 clinics.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • HIV prevention effectiveness of 99%+ with consistent daily PrEP use
  • +2 more outcomes

Companies that use KARADA内科クリニック

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

KARADA内科クリニック technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

KARADA内科クリニック partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

  • Hetero Drugs (ヘテロー Drugs / Hetero社)coreTechnology or IntegrationHetero Drugs is an Indian multinational pharmaceutical company that manufactures Tafero EM (タフェロEM) as a generic antiretroviral. JUST IN CASE imports the generic version (Tafero EM / Instgra) through licensed pharmaceutical importer つばめLabo for use in its PrEP program. Hetero's generic is described as having no significant safety difference from originator drugs and being widely used internationally.
  • KARADA内科クリニック (physical clinic)coreChannel Partner/ Reseller/ DistributorKARADA内科クリニ is the affiliated physical clinic operated by Medical Corporation OURS. It serves as the physical referral destination for patients using the JUST IN CASE online service who prefer or require in-person consultations, as well as the physical location where the online service's medical director and staff are based.
  • 大阪大学 忽那教授 (Professor Kutsuna, Osaka University)flagshipStrategic or Co-development PartnerProfessor Kutsuna of Osaka University, a leading infectious disease researcher, collaborated with Dr. Sato on an in-depth YouTube discussion about DOXY-PEP. This collaboration serves as a key educational and credibility partnership, lending academic authority to JUST IN CASE's DOXY-PEP offering.
  • AbemaTV (アベプラ)minorGTM or Marketing PartnerThe JUST IN CASE DOXY-PEP service was featured on AbemaTV (Abema News), providing earned media coverage that drives awareness and customer acquisition.
  • つばめLabo (Tsubame Labo)coreTechnology or IntegrationLicensed pharmaceutical importer that sources and imports generic antiretrovirals (Tafero EM and Instgra) from Hetero Drugs and other overseas manufacturers for use in the JUST IN CASE PrEP program. Acts as the import compliance and supply chain partner for overseas generic medications.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

KARADA内科クリニック competitors and assessment

Company assessment

Direct peers

  • Nurx: US DTC telehealth platform (now part of Thirty Madison) historically offering PrEP, STI testing, contraception, and home delivery prescriptions. Closely comparable model on PrEP/STI prevention telemedicine with at-home testing integration.
  • あおぞらクリニック (Aozora Clinic): Japanese clinic network with multiple locations explicitly marketing HIV PrEP services online. Closest direct domestic peer — competes for the same PrEP/PEP patient persona in Japan with overlapping telemedicine and consultation offerings.
  • MISTR: US-based, PrEP-focused telehealth platform providing online PrEP prescriptions, at-home STI testing, and direct mail delivery with a similar specialty-prevention model to JUST IN CASE. Direct international comparable for the PrEP-specific vertical.
  • ユナイテッドクリニック (United Clinic): Japanese men's-health clinic chain offering ED, AGA, and sexual health treatments with online consultation services. Comparable patient persona, comparable pricing structure, and comparable focus on discreet access to sensitive prescriptions.
  • プライベートクリニック (Private Clinic): Japanese men's-health clinic specializing in ED, AGA, and PrEP prescriptions with online consultation options. Direct competitor for Japanese patients seeking discreet access to sexual-health prescriptions, with overlapping telemedicine-and-mail-fulfillment pattern.
  • イースト駅前クリニック (East Ekimae Clinic): Large Japanese men's-health clinic chain focused on ED, AGA, and sexual health prescriptions. Comparable in addressing the same stigma-laden, cash-pay, treatment-oriented segment of Japanese patients, though predominantly in-person rather than online-first.

Emerging players

  • フィットクリニック (Fit Clinic): Japanese online clinic offering ED, AGA, weight loss, and other sensitive prescriptions with online consultation and mail delivery. Emerging Japanese comparable with similar product breadth (AGA, ED, weight) that may eventually expand into STI prevention.
  • MEDLEY (Mediplat / Doctors' Job): Japanese digital health company providing online medical content, doctor-matching, and clinician support tools with adjacent exposure to chronic-condition patient engagement. Emerging player with potential to extend into direct DTC prescription telemedicine.

Broad incumbents

  • M3 (Medipal Holdings / m3.com): Large Japanese digital-health and physician platform operating MR-kun, QOL-kun, and other clinician-targeted services, with growing consumer-facing telemedicine. Broad incumbent with the resources to enter or absorb STI-prevention offerings, making it the most plausible large-scale competitive threat.
  • Hims & Hers Health: US-listed DTC telehealth platform offering subscription-based prescription treatments for sensitive conditions (ED, hair loss, PrEP, mental health, weight loss) with discrete home delivery. Highly comparable business model: cash-pay subscription, online consultation, mail fulfillment, DTC sensitive-health positioning at much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

KARADA内科クリニック financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KARADA内科クリニック leadership team

Management profile

Number of profiles

Profiles1 record

KARADA内科クリニック funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KARADA内科クリニック M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KARADA内科クリニック

What does KARADA内科クリニック do?

KARADA内科クリニック runs the JUST IN CASE online telemedicine service that provides remote physician consultations and prescriptions for STI prevention medications, including HIV PrEP (Tafero EM), HIV PEP (Taffic), and DOXY PEP (Doxycycline). Consultations are conducted entirely via LINE without requiring app installation, and prescribed medications are shipped nationwide via Yamato Transport with next-day delivery, discreet plain packaging, and optional locker pickup. The service also sells optional at-home STI test kits for HIV, hepatitis B, syphilis, gonorrhea, and chlamydia.

Is KARADA内科クリニック a public or private company?

KARADA内科クリニック is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was KARADA内科クリニック founded?

KARADA内科クリニック was founded in -1.

Where is KARADA内科クリニック based?

KARADA内科クリニック is headquartered in Tokyo, Japan, in the Asia region.

How does KARADA内科クリニック make money?

Four revenue lines are on record. HIV PEP prescription and medication sales are the primary driver. The others are HIV PrEP prescription and medication sales, DOXY PEP prescription and medication sales and optional postal STI testing.

Who are KARADA内科クリニック's main competitors?

Direct peers on record are Nurx, あおぞらクリニック (Aozora Clinic), MISTR, ユナイテッドクリニック (United Clinic), プライベートクリニック (Private Clinic) and イースト駅前クリニック (East Ekimae Clinic). Emerging players are フィットクリニック (Fit Clinic) and MEDLEY (Mediplat / Doctors' Job). Broad incumbents are M3 (Medipal Holdings / m3.com) and Hims & Hers Health.

Does KARADA内科クリニック have an API?

No public API is recorded for KARADA内科クリニック.

What industry is KARADA内科クリニック in?

KARADA内科クリニック's product category is Online Telemedicine Healthcare Services. Its primary akta.pro industry code is HLALAIAL, Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment, with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 621111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales